Clinirem Sp. z o.o.
- Address
- Ul. Polnocna 24/U1, 20-064 Lublin, Poland
Neurology and Headache Research
At Clinirem Sp. z o.o. in Lublin, clinical research in nervous system diseases focuses on episodic migraine. The studies are designed to evaluate whether a new treatment can help reduce migraine burden and improve symptom control for people living with frequent attacks.
- Focus on episodic migraine within neurological research
- Assessment of a therapy intended to lower monthly migraine days
- Interest in both treatment effectiveness and patient well-being
This research supports better options for preventing migraines and improving everyday functioning for patients affected by recurrent headache disorders.
Autoimmune and Neuromuscular Disease Studies
The site is also conducting work in immune system diseases, with a strong emphasis on generalized myasthenia gravis. These trials aim to understand whether a new therapy can be safe and effective for people with this chronic autoimmune condition that affects muscle strength.
- Research in generalized myasthenia gravis under immunology
- Evaluation of a treatment targeting disease activity and symptom relief
- Clinical interest in safety, tolerability, and therapeutic benefit
Through this work, Clinirem Sp. z o.o. contributes to advancing treatment choices for patients living with complex immune-related disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1Janssen Cilag International2active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International2trials
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinirem Sp. z o.o.
lock Showing 1 of 17 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b, Multi-center, Randomized, Double-blind, Placebo controlled Study of IMVT-1402 Treatment in Adult Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Immunovant Sciences GmbH | Phase II | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Human Normal Immunoglobulin | 3 | Unknown | 2022-10-24 | 2026-07-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.